No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Visudyne is a drug used to treat optical disorders, such as age-related macular degeneration (AMD). It is a photodynamic therapy (PDT) drug, which works by delivering a light-activated drug to the eye to destroy abnormal blood vessels that cause vision loss. Visudyne is administered through an intravenous injection, and the light is then delivered to the eye through a special contact lens. Visudyne is the only PDT drug approved by the U.S. Food and Drug Administration (FDA) for the treatment of AMD.
The Visudyne market is composed of pharmaceutical companies that manufacture and distribute the drug, as well as medical professionals who administer the treatment. Visudyne is used in many countries around the world, and is a popular treatment option for AMD.
Some companies in the Visudyne market include Novartis, Bausch + Lomb, and QLT Inc. Show Less Read more
